David Briere

Bio

David Briere earned his Bachelor of Arts in Psychology and a Biotechnical Certificate from the University of Wisconsin-Milwaukee and Oshkosh. He then pursued his Master of Science in Neuroscience at the University of Hartford in Connecticut.

He began his scientific career as a cancer biologist with Pfizer Inc. in Groton, CT, where he met his wife and started their family. They now have a 13-year-old daughter. Over the next decade, he worked at Pfizer (relocating to San Diego in 2007) and Takeda Pharmaceuticals, taking on increasing responsibilities in generating impactful data sets to transition preclinical projects into approved medicines.

In December 2013, David joined Mirati Therapeutics Inc. as its first scientist. Over the past 11 years, he has played a crucial role in the company's evolution from a start-up to a multi-billion-dollar pharmaceutical company, which was acquired by Bristol-Myers Squibb Inc. in 2023. His contributions include the discovery and development of Krazati (adagrasib), an approved agent that has extended the lives of thousands of lung cancer patients.

David is still excited about making new treatments for cancer. He finds it more rewarding to share his experiences and help the next generation of scientists. His dedication to both research and education continues to drive his professional endeavors.